Gene: FUT1
Official Full Name: fucosyltransferase 1 (H blood group)provided by HGNC
Gene Summary: This gene encodes a Golgi stack membrane protein that is involved in the creation of a precursor of the H antigen, which is required for the final step in the synthesis of soluble A and B antigens. This is one of two genes encoding the galactoside 2-L-fucosyltransferase enzyme. Mutations in this gene are a cause of the H-Bombay blood group. [provided by RefSeq, Aug 2016]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO05097 | FUT1 Knockout cell line (HCT 116) | Human | FUT1 | 1:2~1:4 | Negative | Online Inquiry |
KO05098 | FUT1 Knockout cell line (HEK293) | Human | FUT1 | 1:3~1:6 | Negative | Online Inquiry |
FUT1 Gene Knockout Cell Lines are specifically engineered cellular models designed to investigate the functional implications of the FUT1 gene, which encodes an essential enzyme responsible for the synthesis of certain fucosylated glycans. These knockout cell lines serve as valuable tools for researchers aiming to elucidate the roles of fucosylation in various biological processes, including cell adhesion, signaling, and immune response modulation.
The primary function of FUT1 Gene Knockout Cell Lines lies in their ability to provide insights into the physiological and pathological significance of fucosylated molecules. By nullifying the expression of the FUT1 gene, these cell lines allow for the study of glycobiology in a controlled environment, facilitating the examination of changes in glycan profiles, cellular behaviors, and interactions with pathogens or other cells. This is particularly pertinent in cancer research, where aberrant fucosylation can influence tumor progression and metastasis.
In terms of scientific importance, these cell lines have vast applications in both research and clinical settings. They can be used to screen for new therapeutic targets, develop fucosylation inhibitors, or understand mechanisms of resistance in cancer therapies. The ability to derive insights from these cell lines accelerates the pathway from bench to bedside, informing therapeutic strategies aimed at diseases linked to glycan modifications.
Compared to traditional cell lines, FUT1 Gene Knockout Cell Lines offer a delineated model of specific glycosylation alterations, thus providing enhanced specificity and reliability in research outcomes. Their unique functionality enables precise manipulation of glycan structures, allowing researchers to draw direct correlations between fucosylation and cellular responses.
For researchers and clinicians focused on glycosylation and its implications in health and disease, the FUT1 Gene Knockout Cell Lines represent an indispensable asset that can drive forward the understanding and treatment of complex biological systems. Our company prides itself on delivering high-quality, rigorously validated biological products, empowering the scientific community to advance discoveries with confidence.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.